Blau HM - Search Results

1

Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis.

Ozawa CR, Banfi A, Glazer NL, Thurston G, Springer ML, Kraft PE, McDonald DM, Blau HM. Ozawa CR, et al. Among authors: blau hm. J Clin Invest. 2004 Feb;113(4):516-27. doi: 10.1172/JCI18420. J Clin Invest. 2004. PMID: 14966561 Free PMC article.

2

Muscle-mediated gene therapy.

Blau HM, Springer ML. Blau HM, et al. N Engl J Med. 1995 Dec 7;333(23):1554-6. doi: 10.1056/NEJM199512073332308. N Engl J Med. 1995. PMID: 7477172 Review. No abstract available.

3

Gene therapy--a novel form of drug delivery.

Blau HM, Springer ML. Blau HM, et al. N Engl J Med. 1995 Nov 2;333(18):1204-7. doi: 10.1056/NEJM199511023331808. N Engl J Med. 1995. PMID: 7565977 Review. No abstract available.

4

High-efficiency retroviral infection of primary myoblasts.

Springer ML, Blau HM. Springer ML, et al. Among authors: blau hm. Somat Cell Mol Genet. 1997 May;23(3):203-9. doi: 10.1007/BF02721371. Somat Cell Mol Genet. 1997. PMID: 9330631

5

Immune response and myoblasts that express Fas ligand.

Kang SM, Hoffmann A, Le D, Springer ML, Stock PG, Blau HM. Kang SM, et al. Among authors: blau hm. Science. 1997 Nov 14;278(5341):1322-4. doi: 10.1126/science.278.5341.1322. Science. 1997. PMID: 9411754 No abstract available.

6

VEGF gene delivery to muscle: potential role for vasculogenesis in adults.

Springer ML, Chen AS, Kraft PE, Bednarski M, Blau HM. Springer ML, et al. Among authors: blau hm. Mol Cell. 1998 Nov;2(5):549-58. doi: 10.1016/s1097-2765(00)80154-9. Mol Cell. 1998. PMID: 9844628 Free article.

7

Analysis of immune responses to varicella zoster viral proteins induced by DNA vaccination.

Abendroth A, Slobedman B, Springer ML, Blau HM, Arvin AM. Abendroth A, et al. Among authors: blau hm. Antiviral Res. 1999 Dec 31;44(3):179-92. doi: 10.1016/s0166-3542(99)00066-2. Antiviral Res. 1999. PMID: 10651069 Free article.

8

Inhibition of solid tumor growth by Fas ligand-expressing myoblasts.

Springer ML, Kraft PE, Blau HM. Springer ML, et al. Among authors: blau hm. Somat Cell Mol Genet. 1998 Sep;24(5):281-9. doi: 10.1023/b:scam.0000007131.09916.46. Somat Cell Mol Genet. 1998. PMID: 10696236

9

A novel means of drug delivery: myoblast-mediated gene therapy and regulatable retroviral vectors.

Ozawa CR, Springer ML, Blau HM. Ozawa CR, et al. Among authors: blau hm. Annu Rev Pharmacol Toxicol. 2000;40:295-317. doi: 10.1146/annurev.pharmtox.40.1.295. Annu Rev Pharmacol Toxicol. 2000. PMID: 10836138 Review.

10

Angiogenesis monitored by perfusion with a space-filling microbead suspension.

Springer ML, Ip TK, Blau HM. Springer ML, et al. Among authors: blau hm. Mol Ther. 2000 Jan;1(1):82-7. doi: 10.1006/mthe.1999.0006. Mol Ther. 2000. PMID: 10933915 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

269 results

Search Page

Filters